Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML, Xia H, McGeown J, McIlwain DW, Elbanna M, Craft AA, Kaimakliotis HZ, Sandusky GE, Zhang C, Pili R, Kelley MR, Jerde TJ.
Fishel ML, et al. Among authors: kaimakliotis hz.
Mol Cancer Ther. 2019 Nov;18(11):1947-1960. doi: 10.1158/1535-7163.MCT-18-1166. Epub 2019 Aug 14.
Mol Cancer Ther. 2019.
PMID: 31413178
Free PMC article.